ArticleDiabetes & metabolic syndrome

Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers may be harmful in patients with diabetes during COVID-19 pandemic.

Erkan Cure et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.